H0137B2759A04080 NAD:NLG 11/20/19 #90 A04080
AMENDMENTS TO HOUSE BILL NO. 137
Sponsor: REPRESENTATIVE ZABEL
Printer's No. 2759
Amend Bill, page 1, lines 14 through 21; page 2, lines 1
through 30; page 3, lines 1 through 3; by striking out all of
said lines on said pages and inserting
Section 1. Section 13.7(a) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended to read:
Section 13.7. Drug Overdose Response Immunity.--(a) A
person may not be charged and shall be immune from prosecution
for any offense listed in subsection (b) and for a violation of
probation or parole if the person can establish the following:
(1) law enforcement officers only became aware of the
person's commission of an offense listed in subsection (b)
because the person transported a person experiencing a drug
overdose event to a law enforcement agency, a campus security
office or a health care facility; [or]
(2) all of the following apply:
(i) the person reported, in good faith, a drug overdose
event to a law enforcement officer, the 911 system, a campus
security officer or emergency services personnel and the report
was made on the reasonable belief that another person was in
need of immediate medical attention and was necessary to prevent
death or serious bodily injury due to a drug overdose;
(ii) the person provided his own name and location and
cooperated with the law enforcement officer, 911 system, campus
security officer or emergency services personnel; and
(iii) the person remained with the person needing immediate
medical attention until a law enforcement officer, a campus
security officer or emergency services personnel arrived[.] ;or
(3) law enforcement officers only became aware of the
person's commission of an offense listed in subsection (b)
because the person reasonably believed that they were
experiencing a drug overdose event or in need of immediate
medical assistance and contacted or self-reported to a law
enforcement agency, a campus security office or a health care
facility.
* * *
2019/90NAD/HB0137A04080 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
See A04080 in
the context
of HB0137